Consequences of growth hormone (GH) overexpression and GH resistance

Neuropeptides

Volumn 36, Issue 2-3, 2002, Pages 201-208

  Bartke, A ^a   Chandrashekar, V ^a   Bailey, B ^a   Zaczek, D ^a   Turyn, D ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; INSULIN; LUTEINIZING HORMONE RECEPTOR; METALLOTHIONEIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROLACTIN; PROLACTIN RECEPTOR; SOMATOMEDIN C;

AGING; FERTILITY; GENE OVEREXPRESSION; HORMONE RELEASE; LIFESPAN; LONGEVITY; NEUROENDOCRINE SYSTEM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REPRODUCTION; REVIEW; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0036553049     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.2002.0889     Document Type: Article

References (81)

1. The mouse intraovarian insulin-like growth factor I system: Departures from the rat paradigm
2. Effects of growth hormone on male reproductive functions
3. Mutations prolong life in flies; implications for aging in mammals
4. Growth hormone and aging
5. Does growth hormone prevent or accelerate aging?
6. Neuroendocrine and reproductive consequences of overexpression of growth hormone in transgenic mice
7. Vascular function and blood pressure in GH transgenic mice
8. Enhanced spontaneous locomotor activity in bovine GH transgenic mice involves peripheral mechanisms
9. Impairment of cardiac function and bioenergetics in adult transgenic mice overexpressing the bovine growth hormone gene
10. Oxidative stress in hypopituitary dwarf mice and in transgenic mice overexpressing human and bovine GH
11. Increased plasma corticosterone levels in bovine growth hormone (bGH) transgenic mice: Effects of ACTH, GH and IGF-I on in vitro adrenal corticosterone production
12. Expression of human, but not bovine growth hormone genes promotes development of mammary tumors in transgenic mice
13. Infertility in transgenic mice overexpressing the bovine growth hormone gene: Disruption of the neuroendocrine control of prolactin secretion during pregnancy
14. Effects of bovine growth hormone (bGH) transgene expression or bGH treatment on reproductive functions in female mice
15. Infertility in transgenic mice overexpressing the bovine growth hormone gene: Luteal failure secondary to prolactin deficiency
16. Influence of hypothalamus and ovary on pituitary function in transgenic mice expressing the bovine growth hormone gene and in growth hormone-deficient Ames dwarf mice
17. Testicular endocrine function in growth hormone receptor gene disrupted mice
18. Pituitary and testicular function in growth hormone receptor gene knockout mice
19. Endogenous human growth hormone (GH) modulates the effect of gonadotropin-releasing hormone on pituitary function and the gonadotropin response to the negative feedback effect of testosterone in adult male transgenic mice bearing human GH gene
20. Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice
21. Sexual behavior and fertility of little mice
22. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein
23. Assessment of growth parameters and life span of GHR/BP gene- disrupted mice
24. Glucose metabolism in growth hormone receptor/binding protein gene disrupted mice
25. Deficits in female reproductive function in GH-R-KO mice; role of IGF-I
26. Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice
27. Loss of sensitivity to insulin at early events of the insulin signaling pathway in the liver of growth hormone-transgenic mice
28. Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice
29. Insulin resistance as a predictor of age-related diseases
30. Overexpression of growth hormone genes in transgenic mice shortens free-running periods in constant light
31. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production
32. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissues and exeret different and overlapping developmental effects
33. Enterotoxin septic shock protection and deficient T Helper 2 cytokine production in growth hormone transgenic mice
34. Genetic pathways that regulate ageing in model organisms
35. Free radicals in aging
36. Free radical defenses in the liver and kidney of human growth hormone transgenic mice: Possible mechanisms of early mortality
37. Reduced levels of thyroid hormones, insulin, and glucose, and lower body core temperature in the growth hormone receptor/binding protein knockout mouse
38. Puberty in male growth hormone receptor gene disrupted mice
39. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans
40. Evidence that age-induced decline in memory retention is delayed in growth hormone resistant GH-R-KO (Laron) mice
41. Is the Laron mouse an accurate model of Laron syndrome?
42. Dietary restriction: An experimental approach to the study of the biology of aging
43. Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone releasing factor gene
44. Copulatory behavior and fertility in transgenic male mice expressing human placental growth hormone gene
45. Ethanol and nicotine consumption and preference in transgenic mice overexpressing the bovine growth hormone gene
46. Inhibitory avoidance and appetitive learning in aged normal mice: Comparison with transgenic mice having elevated plasma growth hormone levels
47. Increased glial fibrillary acidic protein (GFAP) levels in the brains of transgenic mice expressing the bovine growth hormone (bGH) gene
48. Fertility of transgenic female mice expressing bovine growth hormone or human growth hormone variant genes
49. Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies
50. The expression of a metallothionein-ovine growth hormone fusion gene in transgenic mice does not impair fertility but results in pathological lesions in the liver
51. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes
52. Insulin exposure and aging theory
53. Decrease in cellular replicative potential in "giant" mice transfected with the bovine growth hormone gene correlates to shortened life span
54. Stimulatory effect of human, but not bovine, growth hormone expression on numbers of tuberinfundibular dopaminergic neurons in transgenic mice
55. Studies of insulin, growth hormone and prolactin binding: Tissue distribution, species variation and characterization
56. Growth response and androgen receptor expression in seminal vesicles from aging transgenic mice expressing human or bovine growth hormone genes
57. Insulin regulates prolactin secretion and mRNA levels in pituitary cells
58. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice
59. Accelerated aging of giant transgenic mice is associated with elevated free radical processes
60. Behavioural rhythmicity in transgenic growth hormone mice: Trade-offs, energetics, and sleep - Wake cycles
61. The growth hormone axis and cognition: Empirical results and integrated theory derived from giant transgenic mice
62. Prolactin replacement during development prevents the dopaminergic deficit in hypothalamic arcuate nucleus in prolactin-deficient Ames dwarf mice
63. The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis
64. Effects of increased production of growth hormone on body composition in mice: Transgenic versus control
65. Growth allometry of the organs in giant transgenic mice
66. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5
67. Disproportional skeletal growth and markedly decreased bond mineral content in growth hormone receptor -/- mice
68. Bovine growth hormone transgenic mice display alterations in locomotor activity and brain monoamine neurochemistry
69. Effects of bovine growth hormone (GH) expression in transgenic mice on serum and pituitary immunoreactive mouse GH levels and pituitary GH-releasing factor binding sites
70. Premature ageing in transgenic mice expressing growth hormone genes
71. Effects of chronic exposure to bovine growth hormone (bGH) on the hypothalamic-pituitary axis in transgenic mice: Relationship to the degree of expression of the PEPCK-bGH hybrid gene
72. Placentomegaly in cloned mouse concepti caused by expansion of the spongiotrophoblast layer
73. Gonadotropin secretion, synthesis, and gene expression in two types of bovine growth hormone transgenic mice
74. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function
75. Growth hormone and fertility in oMtla-oGH transgenic mice
76. Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone
77. Pituitary estrogen receptor α and dopamine subtype 2 receptor gene expression in transgenic mice with overproduction of heterologous growth hormones
78. Effects of long-term elevated serum levels of growth hormone on life expectancy of mice: Lessons from transgenic animal models
79. Ovarian follicles are reduced in number but not function in GH receptor (GHR) knock out (KO) mice
80. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (The Laron mouse)